Probiotic-fermented Qushi decoction alleviates reserpine induced spleen deficiency syndrome by regulating spleen function and gut microbiota dysbiosis.

Abstract

Spleen deficiency syndrome (SDS) is associated with elevated inflammatory factors and dysregulation of gastrointestinal motility hormones and intestinal microbiota. Qushi Decoction (QD), a traditional formula, has not been reported using modern scientific research methods for changes in its probiotic fermented QD (FQD) composition and its potential mechanisms to alleviate SDS. Therefore, the aim of this study was to investigate the splenic protection of FQD in SDS rats by modulating gastrointestinal motility hormones and intestinal microbiota. The results showed that FQD increased total polysaccharides, total protein, total flavonoids and the other active ingredients compared to QD, effectively improved splenic inflammation and apoptosis in SDS rats, and modulated gastrointestinal motility hormones to alleviate diarrhoea and other symptoms. In addition, the dysregulation of the gut microbiota was reversed by increasing the levels of bifidobacterium and decreasing the levels of Escherichia-Shigella and Proteobacteria, which may be related to the regulation of bacterial metabolites to alleviate SDS. These results suggest that FQD is an effective formula for improving SDS. Our findings are beneficial to the implications for the treatment of SDS. This article is protected by copyright. All rights reserved.